5-year cancer biomarker project ready to launch; Scientists find early Alzheimer's biomarker in the eye

> A five-year project which has been dubbed the most important cancer biomarker study ever conducted is set to get underway in the next few months. Story

> A team of scientists at Cedars-Sinai Medical Center in collaboration with colleagues from the Weizmann Institute of Science in Israel and the University of Southern California says that nerve cell-damaging plaque that builds up in the brain with Alzheimer's disease also builds up in the retinas of the eyes--and it shows up earlier as a key biomarker of the disease. Release

> Predictive Biomarker Sciences deployed its computer imaging tech to help direct PharmaGap's clinical strategy for a new cancer drug. PharmaGap CEO Robert McInnis says the process shaves months from its R&D schedule and hundreds of thousands of dollars in development costs. Story

> Australian scientists are adding two new biomarkers to tests for ovarian cancer. The new biomarkers should increase the accuracy of the tests from 94 percent to 97 percent. Story

> Genedata plans to demo the new Refiner MS at the 6th Metabolomics Conference 2010. The MS offers "enhanced capabilities for Mass Spectrometry-based biomarker discovery." Release

> For the first time, new biomarker tests to detect drug-induced kidney injury have been accepted by the Japanese Pharmaceuticals and Medical Devices Agency. Release

> Researchers at the Translational Genomics Research Institute (TGen), the Van Andel Research Institute and the Virginia G. Piper Cancer Center at Scottsdale Healthcare have discovered a biomarker that could help in the treatment of patients with an aggressive type of lung cancer. Release

Suggested Articles

Takeda tapped Roche’s Foundation Medicine to develop tissue- and blood-based companion diagnostic tests for its portfolio of lung cancer therapies.

Cellex has announced plans to develop a rapid coronavirus test that people can fully perform at home, from sample collection to result, using an app.

More than 20 states either don’t release or have incomplete data on the rapid antigen tests now considered key to containing the coronavirus.